By inhibiting TGF-β signaling, TANs can differentiate into an anti-tumor phenotype, characterized by elevated levels of pro-inflammatory cytokines and enhanced cytotoxicity, which induces tumor cell apoptosis and delays tumor growth in vivo [6]. The gene discussed is TGFB1; the disease is neoplasm.